About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: July 2006
Hill Action – New Proposed Legislation Affecting Generics
The Los Angeles Times reports that new legislation has been introduced that would impact pharmaceutical practices regarding generics. The Bill is S. 3695 introduced by Senators Rockefeller, Schumer and Leahy and aims to make an impact of the involvement of … Continue reading
Posted in Proposed Legislation
Comments Off on Hill Action – New Proposed Legislation Affecting Generics
Weekly Roundup – 7-21-06
A very busy week, lots of news, not all of it good. Dichotomy in Two Policies – Gates and Bush – While the Bush Administration vetoed a bill that would have expanded stem cell research on dubious grounds of morality, … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup – 7-21-06
Black Eye for FDA from Union for Concerned Scientists
Today The Union of Concerned Scientists an independent non-profit claiming a membership of 100,000 scientists will hold a press conference to release a survey at a press conference at the National Press Club that, according to its notice will "demonstrate … Continue reading
Posted in FDA Image
Comments Off on Black Eye for FDA from Union for Concerned Scientists
Clouds on the Horizon, Part 4
Sometimes, in the Clouds on the Horizon series, you may see some repetitive subject matter. That is because things don’t happen in a vacuum, but rather in conjunction with one another to bring new emphasis to bear on the matter. … Continue reading
Posted in Pharma Industry Image
Comments Off on Clouds on the Horizon, Part 4
Let’s Talk About Blogs
Yesterday and today I am attending the Second Annual Pharmaceutical and Public Relations Communications Summit. Today I will be presenting on issues related to crisis management. Yesterday, I talked about pharmaceutical companies and blogging. There are a lot of issues … Continue reading
Posted in Current Affairs
3 Comments